CSIMarket


Alexion Pharmaceuticals, Inc.  (ALXN)
Other Ticker:  
 


 

Alexion Pharmaceuticals, Inc.

ALXN's Financial Statements and Analysis



Alexion Pharmaceuticals, Inc. reported in II. Quarter net earnings per share of $2.04 an improvement compare to net loss per share of $-2.05 recorded a year ago and decline of -21.84 % from $2.61 earned in I. Quarter (Mar 31 2019).


II. Quarter
Earnings Per Share Revenues
$ 2.04 $  1,203 Mill
$+4.09     $+158M     +15.15 %



Alexion Pharmaceuticals's Revenue rose by 15.15 % in II. Quarter (Jun 30 2019) year on year, to $1,203 million and advanced by 5.52 % sequentially.


Alexion Pharmaceuticals is

More on ALXN's Income Statement



Alexion Pharmaceuticals's net income of $460 million in II. Quarter increased from net loss of $-457 million II. Quarter a year ago.

Sequentially net earnings fell by -21.79 % from net income of $587.90 million realized in previous quarter.

More on ALXN's Growth

Inventories grew by 6.78 % to $495 million from II. Quarter a year ago, sequentially inventories rose by 2.57 %. In II. Quarter company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -25.48%, to $-47 millions compare to same quarter a year ago and fell by 6.36% from I. Quarter (Mar 31 2019).

More on ALXN's Cash flow Statement


Alexion Pharmaceuticals, Inc. does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals, Inc. earned $ 6.38 cash per share, on a free-cash flow basis 107.73 % of net earning per share.

Book value grew by 4.66 % sequentially to $45.05 per share, 95.66% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 7.26 per share from $ 4.92.

Company issued 0.10 million shares or 0.04 % in II. Quarter.
Interest Coverage Ratio was 16.47. Debt Coverage Ratio was 0.56.

More on ALXN's Dividends

 Market Capitalization (Millions) 26,018
 Shares Outstanding (Millions) 226
 Total Debt (Millions $) 2,565
 Revenue (TTM) (Millions $) 4,499
 Net Income (TTM) (Millions $) 1,334
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) -174
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273




Alexion Pharmaceuticals, Inc. does not pay out common stock dividend.

In trailing twelve-month period Alexion Pharmaceuticals, Inc. earned $ 6.38 cash per share, on a free-cash flow basis 107.73 % of net earning per share.

Book value grew by 4.66 % sequentially to $45.05 per share, 95.66% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 7.26 per share from $ 4.92.

Company issued 0.10 million shares or 0.04 % in II. Quarter.
Interest Coverage Ratio was 16.47. Debt Coverage Ratio was 0.56.

More on ALXN's Balance Sheets

 Market Capitalization (Millions) 26,018
 Shares Outstanding (Millions) 226
 Total Debt (Millions $) 2,565
 Revenue (TTM) (Millions $) 4,499
 Net Income (TTM) (Millions $) 1,334
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) -174
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 2,273


   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BRPM's Profile

Stock Price

BRPM's Financials

Business Description

Fundamentals

Charts & Quotes

BRPM's News

Suppliers

BRPM's Competitors

Customers & Markets

Economic Indicators

BRPM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071